Fulcrum Therapeutics 8-K Report: Key Updates & Insights from January 2025
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Company Information:
- Name: Fulcrum Therapeutics, Inc.
- CIK Number: 0001680581
- Location: 26 Landsdowne Street, Cambridge, MA 02139
- Phone Number: (617) 651-8851
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: January 13, 2025
- SEC File Number: 001-38978
- Financial Instrument:
- Type of Security: Common stock
- Par Value: $0.001 per share
- Ticker Symbol: FULC
- Exchange: NASDAQ
- Entity Information:
- State of Incorporation: Delaware (DE)
- EIN (Employer Identification Number): 47-4839948
- Period Covered:
- The report covers a specific date, which is January 13, 2025.
Insights:
- Fulcrum Therapeutics is a publicly traded company listed on NASDAQ under the ticker symbol FULC.
- The filing indicates an important event or information update through the 8-K form, which could impact investors or stakeholders.
- The exact nature of the event is not detailed in the provided information but should be reviewed in the complete filing for further context and implications.
This summary captures the essential details of the filing and provides a foundation for further analysis or investigation into the company's activities or financial status as of the specified date.